Clinical Trials
9 trialsNCT03823534 2026-04-22
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University
Phase 3 Recruiting
NCT04808531 2022-04-12
NanaBisâ„¢ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
Medlab Clinical
Phase 3 Unknown
NCT02740114 2021-10-18
Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01885182 2019-10-04
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT00626600 2018-10-24
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
Mundipharma Research Limited
Phase 3 Terminated
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01918098 2017-11-14
Targin for Non-cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT02084355 2014-03-12
Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
Gyeongsang National University Hospital
Phase 3 Unknown
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown